TotalMarketCap

Ginkgo Bioworks

DNANYSE United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$646.941 M

$10.06 -13.69%

Close of 6 Nov 2026

As of 6 Nov 2026, Ginkgo Bioworks (DNA) has a market capitalization of $646.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$170.2M

#2328 by revenue

Earnings

-$313.0K

Loss-making

Shares outstanding

63,711,102

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #54Attovia TherapeuticsATTO$684.1M
  2. #55Aura BiosciencesAURA$659.6M
  3. #56Ginkgo BioworksDNA$646.9M
  4. #57Bambusa TherapeuticsBBTX$631.2M
  5. #584D Molecular TherapeuticsFDMT$621.8M

What if Ginkgo Bioworks were worth as much as…

Open the what-if tool →

Gold $28.2T

$438,867.77

Per share 43,647× higher

Bitcoin $1.53T

$23,746.37

Per share 2,362× higher

Apple $5.02T

$77,957.12

Per share 7,753× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Ginkgo Bioworks are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.